A phase I/II clinical trial of cisplatin, and raltitrexed in patients with metastatic breast cancer refractory to anthracycline therapy.

被引：0
|
作者：
Rapoport, B
Mahomed, R
Uys, A
机构：
[1] Univ Pretoria, Dept Med Oncol, ZA-0001 Pretoria, South Africa
[2] Med Oncol Ctr Rosebank, Johannesburg, South Africa
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
140P
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [21] Phase II clinical trial of titanocene dichloride in patients with metastatic breast cancer
    Kroger, N
    Kleeberg, UR
    Mross, K
    Edler, L
    Sass, G
    Hossfeld, DK
    ONKOLOGIE, 2000, 23 (01): : 60 - 62
  • [22] Phase II Trial of Brostallicin and Cisplatin in Patients with Metastatic Triple Negative Breast Cancer.
    Moreno-Aspitia, A.
    Rowland, K. M.
    Liu, H.
    Hillman, D. W.
    Stella, P. J.
    Perez, E. A.
    CANCER RESEARCH, 2011, 71
  • [23] 'Tomudex' (raltitrexed) and cisplatin in the treatment of patients with locally advanced or metastatic head and neck cancer (HNSCC): A Phase I/II study
    Huinink, DTB
    de Jong, RJB
    Verschuur, HP
    Keizer, HJ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S175 - S175
  • [24] Biweekly Raltitrexed Combined With Irinotecan as Second-Line Therapy for Patients With Metastatic Colorectal Cancer: A Phase II Trial
    Cheng, Ke
    Zhou, Yu-Wen
    Chen, Ye
    Li, Zhi-Ping
    Qiu, Meng
    Liu, Ji-Yan
    CANCER CONTROL, 2022, 29
  • [25] Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I–II clinical trial
    C. Campisi
    A. Fabi
    P. Papaldo
    S. Tomao
    B. Massidda
    A. Zappala
    M. T. Ionta
    F. Cognetti
    Cancer Chemotherapy and Pharmacology, 1999, 44 : S1 - S4
  • [26] Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer
    Visonneau, S
    Cesano, A
    Porter, DL
    Luger, SL
    Schuchter, L
    Kamoun, M
    Torosian, MH
    Duffy, K
    Sickles, C
    Stadtmauer, EA
    Santoli, D
    CLINICAL CANCER RESEARCH, 2000, 6 (05) : 1744 - 1754
  • [27] Phase II evaluation of cisplatin and WR2721 for refractory metastatic breast cancer
    Ramnath, N
    LoRusso, P
    Simon, M
    Martino, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (04): : 368 - 372
  • [28] Biweekly Raltitrexed Combined With Irinotecan as Second-Line Therapy for Patients With Metastatic Colorectal Cancer: A Phase II Trial
    Cheng, Ke
    Zhou, Yu-Wen
    Chen, Ye
    Li, Zhi-Ping
    Qiu, Meng
    Liu, Ji-Yan
    CANCER CONTROL, 2022, 29
  • [29] A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer
    Mustacchi, G
    Muggia, M
    Milani, S
    Ceccherini, R
    Leita, ML
    Dellach, C
    ANNALS OF ONCOLOGY, 2002, 13 (11) : 1730 - 1736
  • [30] Biweekly Raltitrexed Combined With Irinotecan as Second-Line Therapy for Patients With Metastatic Colorectal Cancer: A Phase II Trial
    Cheng, Ke
    Zhou, Yu-Wen
    Chen, Ye
    Li, Zhi-Ping
    Qiu, Meng
    Liu, Ji-Yan
    CANCER CONTROL, 2022, 29
12345